 Linda van Dyk
Concepts (228)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gammaherpesvirinae | 21 | 2021 | 38 | 5.080 |
Why?
| | Herpesviridae Infections | 22 | 2021 | 138 | 3.620 |
Why?
| | Virus Latency | 12 | 2021 | 80 | 2.730 |
Why?
| | Gene Expression Regulation, Viral | 9 | 2021 | 80 | 2.720 |
Why?
| | Cyclins | 9 | 2021 | 79 | 2.430 |
Why?
| | Virus Activation | 10 | 2021 | 78 | 2.290 |
Why?
| | Rhadinovirus | 7 | 2015 | 16 | 1.920 |
Why?
| | Viral Proteins | 9 | 2021 | 286 | 1.740 |
Why?
| | RNA Polymerase III | 4 | 2021 | 25 | 1.660 |
Why?
| | Virus Replication | 12 | 2021 | 396 | 1.420 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p18 | 2 | 2018 | 11 | 1.130 |
Why?
| | Promoter Regions, Genetic | 4 | 2021 | 1122 | 0.990 |
Why?
| | RNA, Viral | 5 | 2019 | 565 | 0.980 |
Why?
| | Host-Pathogen Interactions | 5 | 2019 | 296 | 0.820 |
Why?
| | RNA, Untranslated | 3 | 2021 | 113 | 0.770 |
Why?
| | Antigens, Viral | 1 | 2021 | 177 | 0.740 |
Why?
| | Interferon-gamma | 5 | 2014 | 726 | 0.610 |
Why?
| | Autophagy | 4 | 2015 | 236 | 0.610 |
Why?
| | Transcription, Genetic | 3 | 2014 | 1310 | 0.590 |
Why?
| | B-Lymphocytes | 5 | 2017 | 773 | 0.580 |
Why?
| | Nuclear Proteins | 1 | 2021 | 594 | 0.570 |
Why?
| | Mice | 30 | 2021 | 15052 | 0.550 |
Why?
| | Oncogenes | 2 | 2011 | 104 | 0.520 |
Why?
| | Endothelial Cells | 2 | 2011 | 696 | 0.480 |
Why?
| | Virulence Factors | 1 | 2015 | 139 | 0.450 |
Why?
| | Pneumonia, Viral | 2 | 2018 | 344 | 0.440 |
Why?
| | Animals | 34 | 2021 | 32104 | 0.430 |
Why?
| | Tumor Virus Infections | 2 | 2012 | 41 | 0.410 |
Why?
| | MicroRNAs | 4 | 2014 | 607 | 0.410 |
Why?
| | Cell Line | 8 | 2018 | 2651 | 0.360 |
Why?
| | Mice, Inbred C57BL | 12 | 2021 | 4773 | 0.360 |
Why?
| | Genes, Viral | 1 | 2009 | 89 | 0.340 |
Why?
| | Fibroblasts | 6 | 2015 | 839 | 0.330 |
Why?
| | Lymphoproliferative Disorders | 1 | 2009 | 46 | 0.320 |
Why?
| | Pneumonia | 2 | 2015 | 576 | 0.320 |
Why?
| | Mice, Inbred BALB C | 6 | 2015 | 1168 | 0.280 |
Why?
| | Lung | 6 | 2015 | 3673 | 0.270 |
Why?
| | Polymerase Chain Reaction | 3 | 2021 | 1001 | 0.270 |
Why?
| | Gene Expression Regulation | 1 | 2015 | 2353 | 0.260 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 930 | 0.250 |
Why?
| | Flow Cytometry | 4 | 2018 | 1083 | 0.250 |
Why?
| | Molecular Sequence Data | 4 | 2014 | 2790 | 0.220 |
Why?
| | Cells, Cultured | 6 | 2015 | 3914 | 0.210 |
Why?
| | 3T3 Cells | 2 | 2014 | 137 | 0.200 |
Why?
| | Genome, Viral | 3 | 2014 | 121 | 0.190 |
Why?
| | RNA Processing, Post-Transcriptional | 2 | 2014 | 81 | 0.190 |
Why?
| | Luciferases | 1 | 2021 | 140 | 0.190 |
Why?
| | Gene Deletion | 2 | 2015 | 355 | 0.190 |
Why?
| | Herpesviridae | 2 | 2014 | 21 | 0.180 |
Why?
| | Epithelial Cells | 3 | 2015 | 961 | 0.180 |
Why?
| | Lymphocyte Activation | 6 | 2014 | 1057 | 0.170 |
Why?
| | Transfection | 1 | 2021 | 866 | 0.160 |
Why?
| | HEK293 Cells | 1 | 2021 | 602 | 0.160 |
Why?
| | Open Reading Frames | 1 | 2019 | 116 | 0.160 |
Why?
| | Virulence | 2 | 2015 | 231 | 0.160 |
Why?
| | Immunomodulation | 1 | 2019 | 85 | 0.150 |
Why?
| | Mice, Knockout | 6 | 2019 | 2604 | 0.150 |
Why?
| | Pulmonary Fibrosis | 2 | 2014 | 330 | 0.150 |
Why?
| | Base Sequence | 2 | 2014 | 2114 | 0.150 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2015 | 69 | 0.140 |
Why?
| | DNA Primers | 2 | 2015 | 514 | 0.140 |
Why?
| | Rhinovirus | 2 | 2015 | 41 | 0.140 |
Why?
| | Interferons | 2 | 2015 | 152 | 0.140 |
Why?
| | Interleukin-10 | 1 | 2019 | 299 | 0.140 |
Why?
| | Gene Knockdown Techniques | 1 | 2018 | 302 | 0.140 |
Why?
| | Mice, Transgenic | 4 | 2019 | 1970 | 0.140 |
Why?
| | Autoimmunity | 2 | 2013 | 822 | 0.140 |
Why?
| | Cell Survival | 2 | 2011 | 1024 | 0.140 |
Why?
| | Neoplasms | 2 | 2009 | 2118 | 0.130 |
Why?
| | PTEN Phosphohydrolase | 1 | 2017 | 142 | 0.130 |
Why?
| | Disease Models, Animal | 7 | 2019 | 3580 | 0.130 |
Why?
| | RNA, Transfer | 2 | 2014 | 119 | 0.130 |
Why?
| | B-Cell Activating Factor | 1 | 2015 | 18 | 0.130 |
Why?
| | Neutralization Tests | 1 | 2015 | 63 | 0.130 |
Why?
| | Th17 Cells | 1 | 2015 | 59 | 0.130 |
Why?
| | Trehalose | 1 | 2015 | 29 | 0.120 |
Why?
| | Antigen-Presenting Cells | 1 | 2015 | 153 | 0.120 |
Why?
| | Picornaviridae Infections | 1 | 2015 | 30 | 0.120 |
Why?
| | Diagnostic Imaging | 1 | 2018 | 297 | 0.120 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2014 | 346 | 0.120 |
Why?
| | Immunoblotting | 1 | 2015 | 281 | 0.120 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2019 | 965 | 0.120 |
Why?
| | Virus Diseases | 1 | 2017 | 200 | 0.120 |
Why?
| | Polyproteins | 1 | 2014 | 2 | 0.120 |
Why?
| | Antibodies, Neutralizing | 2 | 2015 | 222 | 0.120 |
Why?
| | Bone Marrow Transplantation | 1 | 2015 | 239 | 0.120 |
Why?
| | RNA, Messenger | 2 | 2019 | 2574 | 0.120 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2014 | 198 | 0.120 |
Why?
| | Blotting, Northern | 1 | 2014 | 194 | 0.120 |
Why?
| | Transcriptome | 1 | 2019 | 736 | 0.110 |
Why?
| | RNA Folding | 1 | 2014 | 33 | 0.110 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2013 | 21 | 0.110 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2018 | 699 | 0.110 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2014 | 170 | 0.110 |
Why?
| | T-Box Domain Proteins | 1 | 2013 | 93 | 0.110 |
Why?
| | Oncogene Proteins | 2 | 2011 | 53 | 0.110 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2014 | 139 | 0.100 |
Why?
| | Clonal Anergy | 1 | 2012 | 53 | 0.100 |
Why?
| | B-Lymphocyte Subsets | 1 | 2012 | 68 | 0.100 |
Why?
| | Pseudomonas aeruginosa | 1 | 2014 | 301 | 0.100 |
Why?
| | Immunophenotyping | 3 | 2019 | 277 | 0.100 |
Why?
| | Biological Assay | 1 | 2012 | 114 | 0.100 |
Why?
| | Terminator Regions, Genetic | 1 | 2011 | 12 | 0.100 |
Why?
| | Nucleic Acid Conformation | 2 | 2014 | 672 | 0.090 |
Why?
| | Immune Tolerance | 1 | 2012 | 332 | 0.090 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2009 | 150 | 0.090 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2012 | 221 | 0.080 |
Why?
| | Antiviral Agents | 1 | 2015 | 649 | 0.080 |
Why?
| | Immunoglobulin G | 1 | 2013 | 781 | 0.080 |
Why?
| | Antibodies, Viral | 1 | 2012 | 527 | 0.080 |
Why?
| | Pulmonary Circulation | 1 | 2009 | 410 | 0.070 |
Why?
| | Humans | 12 | 2021 | 115741 | 0.070 |
Why?
| | Cyclin-Dependent Kinases | 2 | 2005 | 110 | 0.070 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 795 | 0.070 |
Why?
| | Models, Biological | 2 | 2012 | 1646 | 0.070 |
Why?
| | Survival Analysis | 1 | 2009 | 1219 | 0.070 |
Why?
| | Clone Cells | 1 | 2005 | 248 | 0.060 |
Why?
| | Postoperative Complications | 1 | 2015 | 2164 | 0.060 |
Why?
| | Sequence Alignment | 1 | 2005 | 327 | 0.060 |
Why?
| | Signal Transduction | 1 | 2017 | 4541 | 0.060 |
Why?
| | Apoptosis | 3 | 2014 | 2377 | 0.060 |
Why?
| | Chromosome Mapping | 1 | 2005 | 489 | 0.060 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2009 | 511 | 0.060 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2015 | 317 | 0.050 |
Why?
| | CD8 Antigens | 1 | 2003 | 69 | 0.050 |
Why?
| | Inflammation | 2 | 2014 | 2500 | 0.050 |
Why?
| | Immunologic Memory | 1 | 2005 | 314 | 0.050 |
Why?
| | Sequence Analysis, RNA | 1 | 2005 | 391 | 0.050 |
Why?
| | Cytokines | 3 | 2019 | 1853 | 0.050 |
Why?
| | Genes, bcl-2 | 1 | 2002 | 20 | 0.050 |
Why?
| | Immunocompromised Host | 1 | 2003 | 197 | 0.050 |
Why?
| | HeLa Cells | 2 | 2013 | 567 | 0.050 |
Why?
| | Gene Targeting | 1 | 2000 | 75 | 0.040 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2005 | 693 | 0.040 |
Why?
| | Mice, SCID | 1 | 2000 | 321 | 0.040 |
Why?
| | Cell Cycle | 2 | 1999 | 546 | 0.040 |
Why?
| | Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 1999 | 21 | 0.040 |
Why?
| | Monocyte Chemoattractant Proteins | 2 | 2009 | 8 | 0.040 |
Why?
| | NIH 3T3 Cells | 1 | 2019 | 137 | 0.040 |
Why?
| | Chemokine CCL2 | 2 | 2009 | 105 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2005 | 1537 | 0.040 |
Why?
| | Genes, Reporter | 1 | 2019 | 257 | 0.040 |
Why?
| | Lymphoma | 1 | 1999 | 178 | 0.040 |
Why?
| | Rabbits | 1 | 1999 | 752 | 0.040 |
Why?
| | G1 Phase | 1 | 1998 | 68 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 1999 | 309 | 0.040 |
Why?
| | Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | 1 | 2017 | 13 | 0.040 |
Why?
| | Chronic Disease | 1 | 2003 | 1598 | 0.040 |
Why?
| | Receptors, CXCR4 | 1 | 2017 | 78 | 0.030 |
Why?
| | Cell Separation | 1 | 2018 | 293 | 0.030 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2017 | 107 | 0.030 |
Why?
| | Lymphocytes | 1 | 1998 | 344 | 0.030 |
Why?
| | Antibody Formation | 1 | 2017 | 273 | 0.030 |
Why?
| | Aging | 1 | 2005 | 1632 | 0.030 |
Why?
| | Interleukin-17 | 1 | 2015 | 106 | 0.030 |
Why?
| | T-Cell Antigen Receptor Specificity | 1 | 2014 | 41 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2015 | 154 | 0.030 |
Why?
| | Immunoenzyme Techniques | 1 | 2015 | 193 | 0.030 |
Why?
| | Gene Order | 1 | 2014 | 24 | 0.030 |
Why?
| | Smad3 Protein | 1 | 2014 | 41 | 0.030 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2014 | 88 | 0.030 |
Why?
| | Poly (ADP-Ribose) Polymerase-1 | 1 | 2014 | 40 | 0.030 |
Why?
| | Computational Biology | 1 | 2018 | 537 | 0.030 |
Why?
| | Respiratory System | 1 | 2015 | 141 | 0.030 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 1998 | 630 | 0.030 |
Why?
| | Gene Expression | 1 | 2019 | 1436 | 0.030 |
Why?
| | Cell Proliferation | 2 | 2015 | 2194 | 0.030 |
Why?
| | Toll-Like Receptor 7 | 1 | 2013 | 35 | 0.030 |
Why?
| | Receptors, Interferon | 1 | 2013 | 47 | 0.030 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2014 | 156 | 0.030 |
Why?
| | Fibrosis | 1 | 2015 | 457 | 0.030 |
Why?
| | Interferon-beta | 1 | 2013 | 79 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2019 | 1218 | 0.030 |
Why?
| | Bleomycin | 1 | 2014 | 232 | 0.030 |
Why?
| | Mice, 129 Strain | 1 | 2012 | 77 | 0.030 |
Why?
| | Blotting, Western | 1 | 2015 | 1153 | 0.030 |
Why?
| | Mice, Inbred MRL lpr | 1 | 2012 | 38 | 0.030 |
Why?
| | Retinoblastoma Protein | 2 | 2005 | 52 | 0.030 |
Why?
| | Models, Immunological | 1 | 2012 | 92 | 0.020 |
Why?
| | Lupus Nephritis | 1 | 2012 | 52 | 0.020 |
Why?
| | Interleukins | 1 | 2013 | 238 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 1999 | 1756 | 0.020 |
Why?
| | 3' Flanking Region | 1 | 2011 | 7 | 0.020 |
Why?
| | Membrane Glycoproteins | 1 | 2013 | 431 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2014 | 2000 | 0.020 |
Why?
| | Algorithms | 1 | 2018 | 1500 | 0.020 |
Why?
| | Male | 5 | 2017 | 56050 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2018 | 1405 | 0.020 |
Why?
| | Acute Disease | 1 | 2012 | 914 | 0.020 |
Why?
| | Peptides | 1 | 2014 | 864 | 0.020 |
Why?
| | Dendritic Cells | 1 | 2012 | 438 | 0.020 |
Why?
| | Mutation | 2 | 2014 | 3364 | 0.020 |
Why?
| | Biomarkers | 1 | 2019 | 3471 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2011 | 732 | 0.020 |
Why?
| | Fluorescein-5-isothiocyanate | 1 | 2008 | 37 | 0.020 |
Why?
| | Phosphorylation | 2 | 2005 | 1571 | 0.020 |
Why?
| | Muscle, Smooth, Vascular | 1 | 1990 | 420 | 0.020 |
Why?
| | Female | 5 | 2017 | 60018 | 0.020 |
Why?
| | Th1 Cells | 1 | 2008 | 125 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 2009 | 446 | 0.020 |
Why?
| | Th2 Cells | 1 | 2008 | 157 | 0.020 |
Why?
| | Phosphotransferases | 1 | 2005 | 25 | 0.020 |
Why?
| | Cyclin-Dependent Kinase 4 | 1 | 2005 | 33 | 0.020 |
Why?
| | Cyclin-Dependent Kinase 2 | 1 | 2005 | 32 | 0.020 |
Why?
| | CDC2 Protein Kinase | 1 | 2005 | 25 | 0.020 |
Why?
| | Cyclin-Dependent Kinase 6 | 1 | 2005 | 37 | 0.020 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2005 | 107 | 0.020 |
Why?
| | Up-Regulation | 1 | 2008 | 820 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2005 | 267 | 0.010 |
Why?
| | Autoantibodies | 1 | 2012 | 1360 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 214 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2005 | 523 | 0.010 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2005 | 449 | 0.010 |
Why?
| | Histones | 1 | 2005 | 540 | 0.010 |
Why?
| | Protein Binding | 1 | 2005 | 1917 | 0.010 |
Why?
| | Brain | 1 | 1990 | 2373 | 0.010 |
Why?
| | S Phase | 1 | 1998 | 69 | 0.010 |
Why?
| | Jurkat Cells | 1 | 1998 | 128 | 0.010 |
Why?
| | Enzyme Activation | 1 | 1998 | 793 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 1998 | 1730 | 0.010 |
Why?
| | Time Factors | 1 | 2002 | 6171 | 0.010 |
Why?
| | CD4 Antigens | 1 | 1990 | 124 | 0.010 |
Why?
| | Vasculitis | 1 | 1990 | 71 | 0.010 |
Why?
| | Histocompatibility Antigens Class II | 1 | 1990 | 353 | 0.000 |
Why?
| | Spleen | 1 | 1990 | 492 | 0.000 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 1990 | 342 | 0.000 |
Why?
| | Antibodies, Monoclonal | 1 | 1990 | 1265 | 0.000 |
Why?
| | Phenotype | 1 | 1990 | 2839 | 0.000 |
Why?
|
|
van Dyk's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|